Dose-response relationships of 3 triple-drug combinations and their component agents were explored, allowing the relative contributions of single agents in each combination to be assessed.
In addition, the study investigated whether significant pharmacokinetic interactions occur between the component agents, and evaluated the safety profile and antitumour activity of the XELIRI regimen.
Capecitabine/paclitaxel combination therapy is generally well tolerated, demonstrating a predictable safety profile consistent with the safety profiles of the component agents.
Furthermore, we had more frequent examinations and safer criteria for the dose modification than in the ACCORD 11 study, which might have led to the low dose intensity of some component agents.
Indeed, in most patients for which blood pressure targets are difficult to achieve the use of multidrug combinations will often produce greater blood pressure reduction at lower doses of the component agents, resulting in fewer adverse events [ 47, 48].
Each isotonic 40 mM KCl alone and isotonic 40 mM KCl plus mepivacaine treatment was made by adding the component agents into the isotonic 40 mM KCl immediately before use.
Generally, an apiceutical extract is a "multiple-component agent" and presents different chemical classes of compounds like phenolic acids, esters, flavonoids and terpenes, and each chemical class display a particular chemical reactivity and is likely to react with light, air, water and other extrinsic factors promoting rapid degradation or inactivation of biological activity.
During the design phase and selection of reusable components, agents are interactions are analysed to provide pointers to identify of the most suitable reusable component.
The system consists of three main Industry 4.0 components: agents, service-oriented architecture (SOA) and a semantic modelling of the process chain.
